Internal Medicine, Endocrinology, Diabetes, & Metabolism · Wilkes Barre, PA
NPI
1457485625
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
675 Baltimore Dr
Wilkes Barre, PA, 18702
Phone (570) 808-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
1,206 services
Medicare patients, 2024
708
Average age 73
Drug cost, 2024
$2.2M
4,926 prescriptions
Company payments, 2025
$83.42
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian C Jameson was code 77080 (standard x-ray), 436 times for 436 patients. In total Brian C Jameson billed 1,206 services in 20 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77080 Standard X-ray | Office | 436 | 436 | $8.90 | $3,881 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 210 | 186 | $11.81 | $2,480 |
| 99214 Office E&M - Established | Office | 192 | 175 | $67.40 | $13K |
| 77092 Standard X-ray | Office | 181 | 181 | $7.16 | $1,296 |
| 95251 Test - Miscellaneous | Office | 42 | 34 | $25.57 | $1,074 |
| 99215 Office E&M - Established | Office | 41 | 37 | $109.83 | $4,503 |
| 99204 Office E&M - New | Office | 19 | 19 | $98.17 | $1,865 |
| 99213 Office E&M - Established | Office | 17 | 16 | $50.23 | $854 |
| 99214 Office E&M - Established | Facility | 13 | 13 | $64.45 | $838 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 12 | 12 | $11.41 | $137 |
| 10005 Other Organ Systems | Facility | 12 | 12 | $55.03 | $660 |
By year: 2022 $26K for 547 services; 2023 $32K for 878 services; 2024 $32K for 1,206 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian C Jameson prescribed most often to Medicare patients was Levothyroxine Sodium, with 862 prescriptions and refills. In total Brian C Jameson wrote 4,926 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 862 | 2,287 | 294 | $14K |
| Ozempic Semaglutide | 261 | 417 | 77 | $387K |
| Synthroid Levothyroxine Sodium | 241 | 556 | 65 | $20K |
| Jardiance Empagliflozin | 236 | 455 | 74 | $255K |
| Metformin Hcl Er Metformin Hcl | 171 | 383 | 53 | $3,350 |
| Metformin Hcl Generic | 149 | 429 | 59 | $1,847 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 135 | 316 | 59 | $20K |
| Hydrocortisone Generic | 123 | 205 | 31 | $5,039 |
| Novolog Flexpen Insulin Aspart | 120 | 225 | 58 | $37K |
| Trulicity Dulaglutide | 106 | 173 | 40 | $165K |
| Atorvastatin Calcium Generic | 96 | 218 | 31 | $1,509 |
| Mounjaro Tirzepatide | 91 | 131 | 30 | $138K |
| Novolog Insulin Aspart | 70 | 115 | 24 | $21K |
| Glimepiride Generic | 67 | 167 | 24 | $1,459 |
| Glipizide Er Glipizide | 64 | 160 | 18 | $1,663 |
Brand drugs: 2,093 claims; generic drugs: 2,428 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian C Jameson $83.42 ($83.42 in general payments such as food, travel and fees) from 1 company. The largest payer was Lilly USA, LLC with $83.42.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 1 | $83.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.